Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-28T06:46:19.320Z Has data issue: false hasContentIssue false
  • English
  • Français

Focused Microbiological Surveillance and Gram-Negative Beta-Lactamase-Mediated Resistance in an Intensive Care Unit

Published online by Cambridge University Press:  02 January 2015

E.A. Bryce  and
J.A. Smith
E.A. Bryce*
Affiliation:
Division of Medical Microbiology, Vancouver Hospital, Vancouver, British Columbia, Canada
J.A. Smith
Affiliation:
Division of Medical Microbiology, Vancouver Hospital, Vancouver, British Columbia, Canada
*
Division of Medical Microbiology, Vancouver Hospital, 855 W 12th Ave., Vancouver, BC V5.Z 1M9, Canada
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To evaluate the use of focused surveillance in following resistance patterns within an intensive care unit (ICU).

Design:

Antibiograms of 167 gram-negative isolates from ICU patients were compared to the hospitalwide antibiograms. ICU isolates were examined for the newer forms of beta-lactamase resistance. An outbreak of multiresistant Pseudomonas aeruginosa during the survey illustrated the usefulness of focused surveillance in early intervention and containment.

Setting:

A 700-bed adult tertiary care hospital with a 16-bed medical and surgical ICU.

Results:

Hospitalwide and ICU antibiograms of the Enterobacteriaceae were similar. However, resistance of P aeruginosa in the ICU was underestimated by hospitalwide rates. Susceptibility of ICU isolates to ceftazidime, ciprofloxacin, and piperacillin was 54%, 54%, and 42%, compared with 81%, 77%, and 85%, respectively, in the hospital at large. Thirty-five percent of isolates exhibited one of the newer forms of beta-lactamase-mediated resistance, with 17% of isolates exhibiting Class I cephalosporinase production.

Conclusion:

Targeted survey of high antibiotic-use hospital units should be used to study bacterial epidemiology, rather than relying on general hospital data to evaluate patterns of antimicrobial resistance. Monitoring of potential problem areas leads to prompt identification of changes in resistance and allows early intervention.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 16 , Issue 6 , June 1995 , pp. 331 - 334
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Livermore, DM. Mechanisms of resistance to β-lactam antibiotics. Scand J Infect Dis 1991:78:7–16.Google ScholarPubMed
2. Sanders, CC, Sanders, WG Jr. β-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect. Dis 1992;15:824–839.CrossRefGoogle ScholarPubMed
3. Bush, K. Classification of β-lactamases: groups 2c, 2d, 2e, 3, and 4. Antimicrob Agents Chemother 1989;33:271–276.Google Scholar
4. Stratton, CW Ratner, H, Johnston, PG. Schaffner W Focused microbiological surveillance by specific hospital unit as a more sensitive means of defining antimicrobial resistance problems. Diagn Microbial Infect Dis 1992;15:11S–18S.Google Scholar
5. Jones, RN. The current and future impact of antimicrobial resistance among nosocomial bacterial pathogens. Diagn Microbial Infec Dis 1992;15:3S–10S.CrossRefGoogle ScholarPubMed
6. National Committee for Clinical Laboratory Standards 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2 (M100S4), NCCLS, Villanova, PA; 1993.Google Scholar
7. Jarlier, V, Nicolas, M, Fournier, G. Philippon, A. Extended broad-spectrum p-lactamases conferring transferable resistance to newer β-lactam agents in enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867–877.CrossRefGoogle Scholar
8. Sanders, CC. β-lactamase of gram-negative bacteria: new challenges for new drugs. Clin Infect Dis 1992;14:1089–1099.Google Scholar
9. Jarvis, W, Edwards, JR, Culver, DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am J Med 1991;3B(suppl):185–191.Google Scholar
10. Katsanis, GP: Spargo, J, Ferraro, MJ, et al. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. J Clin Microbial 1994;32:691–696.Google Scholar